INNATE PHARMA (EPA:IPH) INNATE PHARMA RELEASES ITS FINANCIAL CALENDAR FOR 2020

Retour

Directive transparence : information réglementée

04/12/2019 07:00

24/06/2020 07:00

U.S. Food and Drug Administration lifts partial clinical hold on lacutamab...

12/05/2020 07:00

Innate Pharma First Quarter 2020 Report

13/01/2020 23:00

French regulatory agency agrees lacutamab TELLOMAK trial can resume...

09/01/2020 07:00

INNATE PHARMA PROVIDES UPDATE FROM REGULATORY AGENCIES ON LACUTAMAB...

02/01/2020 07:00

The European Medicines Agency accepts the regulatory submission for...

13/12/2019 07:00

Innate Pharma Provides Update on Lacutamab Tellomak Trial

08/12/2019 15:00

Innate Pharma highlights FDA-approved Lumoxiti® at ASH 2019

04/12/2019 07:00

INNATE PHARMA RELEASES ITS FINANCIAL CALENDAR FOR 2020

03/12/2019 07:00

Innate Pharma Certified as a Great Place to Work®

13/11/2019 07:00

Innate Pharma third quarter 2019 report

Voir tous les communiqués de INNATE PHARMA